Nevro Files Patent Suit Against Stimwave
Executive Summary
Chronic pain treatment company Nevro has filed suit against rival Stimwave Tech alleging patent infringement.
You may also be interested in...
Nevro, Boston Sci Settle Spine-Stim Patent Dispute
Nevro and Boston Scientific have resolved a patent dispute involving spinal cord stimulation technologies.
Market Intel: Pain Management II: Competition Intensifies For Spinal Cord Stim Market's Big Three
In the global pain management market, spinal cord stimulation (SCS) systems are expected to continue to be the fastest-growing segment with increasing competition among device manufacturers to develop innovative, targeted therapies. In this second article of a two-part series, we'll discuss the competitive landscape in the SCS market, the key players, emerging companies and their respective technologies.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.